Myasthenia gravis trials in Denmark

In Denmark 8 Also abroad 123

8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients with Myasthenia Gravis
Where
Aarhus N, Copenhagen Oe
Age
18 years and over
People
59 worldwide
Run by
NMD Pharma A/S
See details and how to join2023-507539-40-00 · EU 2023-507539-40-00
Phase 3Taking people
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Where
Aalborg, Copenhagen Oe
Age
18 years and over
People
199 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT04951622 · EU 2023-504152-97-00
No phaseTaking people
Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360
Where
Aarhus, Copenhagen
Age
18 years and over
People
100 worldwide
Run by
Ad scientiam
See details and how to joinNCT07323316
Phase 3Taking people
A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)
Where
Copenhagen, Gistrup
Age
18 years to 80 years
People
195 worldwide
Run by
Dianthus Therapeutics
See details and how to joinNCT07647510 · EU 2026-525298-38-00
Phase 1/2Taking people
A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF/APRIL Inhibitor, in Patients with Generalized Myasthenia Gravis
Where
Copenhagen Oe
Age
18 years and over
People
38 worldwide
Run by
Aurinia Pharmaceuticals Inc.
See details and how to join2025-525127-27-00 · EU 2025-525127-27-00
Phase 1/2Not yet taking people in Denmark
A double-blind, randomised, placebo-controlled, first-in-human (FIH) Phase I/IIa, multi-centre trial to assess safety, tolerability, and immune response of single and multiple ascending doses of TOL2 (Immune Tolerising Agent) in patients with generalised myasthenia gravis
Where
Copenhagen Oe
Age
18 years and over
People
55 worldwide
Run by
Bonsai Biotherapeutics AB
See details and how to join2024-515627-10-00 · EU 2024-515627-10-00
Phase 2Taking people
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Where
Aarhus, Copenhagen
Age
18 years and over
People
84 worldwide
Run by
NMD Pharma A/S
See details and how to joinNCT06414954
Phase 3Taking people
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Where
Copenhagen Oe
Age
18 years to 80 years
People
231 worldwide
Run by
Immunovant Sciences GmbH
See details and how to joinNCT07039916 · EU 2024-515979-35-00